ClinicalTrials.gg
Enrolling by invitationNCT06582238Updated Sep 3, 2024

Dentine Hypersensitivity Management KAP Study

An observational study in Dentin Sensitivity, sponsored by Muhammad Modu. Enrolling by invitation at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2024-09-03.

Sponsored by Muhammad Modu · Observational

From the registry’s dates

  • Primary completion was expected by Mar 2025, 1 year 7 months ago, but the record still lists the study as enrolling by invitation.
Study type
Observational
Model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
500
Sex
All
01

Study summary

The study aims to assess and compare the knowledge, attitudes, and practices of Egyptian and Nigerian dentists on etiology, diagnosis, and management of DH. Also to identify if level of education, culture and environment have influence in the diagnosis and management of DH.

Read the detailed description

Diagnosis of dentin hypersensitivity is a challenge faced by dentists with different educational levels and the condition might be overlooked and not properly managed leading to persistent pain and poor quality of life for patients. Till the now, literature lacks rigorous guidelines for systematic diagnosis, prevention, categorization of severity and management of dentin hypersensitivity.

This study intends to spot the light on the current approaches adopted by dentists in Egypt and Nigeria towards diagnosis and management of Dentine Hypersensitivity. It also intends to compare the findings and identify the influence of geographic location, different educational levels, and degree of dental education in the management of Dentine Hypersensitivity

02

Conditions studied

  • Dentin Sensitivity

Browse trials for

03

In context

Dentin Sensitivity

288 studies on the registry are indexed under Dentin Sensitivity; 46 are open to participants now.

Browse Dentin Sensitivity studies →

Lead sponsor

This is the only study on the registry with Muhammad Modu as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Levels of Education

  • Consultant/Fellow/Professor
  • Specialist/Senior Lecturer
  • Resident/Registrar/Post Graduate Student
  • BDS

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Must be a Dentist
  • Must be in clinical practice
  • Must be practicing in Egypt or Nigeria
  • Willingly CHOOSE to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Dentists that choose NOT to participate in the study
05

Study design

Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
500 participants (estimated)
Patient registry
No

Groups and cohorts

  • Egyptian Dentists

    Dentists (at various levels of education and years of practice) practicing in Egypt

    Other: Dentists in Clinical Practice

  • Nigerian Dentists

    Dentists (at various levels of education and years of practice) practicing in Nigeria

    Other: Dentists in Clinical Practice

Interventions

  • OtherDentists in Clinical Practice

    Experience in managing Dentine Hypersensitivity

06

What researchers measure

Primary outcomes

  1. Knowledge

    % of Dentists with adequate knowledge of appropriate etiology diagnosis and management of DH among practicing dentists in Egypt and Nigeria using a validated questionnaire with options of various etiologies, diagnosis and management options. the subject chooses yes, no or i don't know.

    Time frame: 6 months

Secondary outcomes

  1. Comparison

    Comparison of Knowledge and management practices of dentists in Egypt and Nigeria in the management of dentine sensitivity

    Time frame: 6 months

07

Study locations

1 site
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2024; primary completion for Mar 2025, 4 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 23, 2024
First posted
Sep 3, 2024
StartEst.
Oct 21, 2024
Primary completionEst.
Mar 20, 2025
CompletionEst.
Apr 11, 2025
Last update
Sep 3, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 3, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06582238
Lead sponsor
Muhammad Modu
Collaborators
Cairo University
Responsible party
Sponsor
First posted
Sep 3, 2024
Start date
Oct 21, 2024 (estimated)
Primary completion
Mar 20, 2025 (estimated)
Completion
Apr 11, 2025 (estimated)
Last update
Sep 3, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion